EP1379227A4 - Micro-emulsions en tant que precurseurs de nanoparticules solides - Google Patents

Micro-emulsions en tant que precurseurs de nanoparticules solides

Info

Publication number
EP1379227A4
EP1379227A4 EP02719324A EP02719324A EP1379227A4 EP 1379227 A4 EP1379227 A4 EP 1379227A4 EP 02719324 A EP02719324 A EP 02719324A EP 02719324 A EP02719324 A EP 02719324A EP 1379227 A4 EP1379227 A4 EP 1379227A4
Authority
EP
European Patent Office
Prior art keywords
microemulsions
precursors
solid nanoparticles
nanoparticles
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02719324A
Other languages
German (de)
English (en)
Other versions
EP1379227A1 (fr
Inventor
Russell John Mumper
Michael Jay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/812,884 external-priority patent/US7153525B1/en
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of EP1379227A1 publication Critical patent/EP1379227A1/fr
Publication of EP1379227A4 publication Critical patent/EP1379227A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP02719324A 2001-03-21 2002-03-21 Micro-emulsions en tant que precurseurs de nanoparticules solides Withdrawn EP1379227A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/812,884 US7153525B1 (en) 2000-03-22 2001-03-21 Microemulsions as precursors to solid nanoparticles
US812884 2001-03-21
PCT/US2002/008936 WO2002076441A1 (fr) 2001-03-21 2002-03-21 Micro-emulsions en tant que precurseurs de nanoparticules solides

Publications (2)

Publication Number Publication Date
EP1379227A1 EP1379227A1 (fr) 2004-01-14
EP1379227A4 true EP1379227A4 (fr) 2007-12-12

Family

ID=25210874

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02719324A Withdrawn EP1379227A4 (fr) 2001-03-21 2002-03-21 Micro-emulsions en tant que precurseurs de nanoparticules solides

Country Status (3)

Country Link
EP (1) EP1379227A4 (fr)
CA (1) CA2445125A1 (fr)
WO (1) WO2002076441A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
AU2003903296A0 (en) * 2003-06-30 2003-07-10 Raustech Pty Ltd Chemical compositions of matter
US7803366B2 (en) 2004-05-07 2010-09-28 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
EP1597973A1 (fr) * 2004-05-18 2005-11-23 Nestec S.A. Emulsion d'huile dans l'eau pour livraison
EP1598060A1 (fr) 2004-05-18 2005-11-23 Nestec S.A. Émulsion huile dans eau pour livraison
US7534448B2 (en) * 2004-07-01 2009-05-19 Yale University Methods of treatment with drug loaded polymeric materials
ES2318531T3 (es) * 2004-09-14 2009-05-01 Nanodel Technologies Gmbh Vehiculo de administracion que contiene nanoparticulas.
EP1661559A1 (fr) * 2004-11-25 2006-05-31 NanoDel Technologies GmbH Systéme de délivrance produit par un procédé de miniémulsion
WO2006056362A2 (fr) * 2004-11-25 2006-06-01 Nanodel Technologies Gmbh Vehicule d'administration fabrique au moyen du procede de miniemulsion
ES2348743T3 (es) * 2005-11-22 2010-12-13 Nestec S.A. Emulsion aceite-en-agua y su uso para administrar una funcionalidad.
EP1956920A1 (fr) * 2005-11-22 2008-08-20 Nestec S.A. Phase lipidique facilement dispersible
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP1815851A1 (fr) * 2006-02-03 2007-08-08 NanoDel Technologies GmbH Nanoparticules pour l'administration de médicaments
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
US8889117B2 (en) 2007-02-15 2014-11-18 Yale University Modular nanoparticles for adaptable vaccines
US11246831B2 (en) 2007-03-30 2022-02-15 Particle Sciences, Inc. Particle formulations and uses thereof
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
ES2385080B1 (es) * 2010-12-21 2013-05-10 Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea Nanopartículas lipídicas para el tratamiento de enfermedades oculares.
WO2013163176A1 (fr) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticules pour le traitement d'allergies
CN105188741A (zh) 2013-04-03 2015-12-23 阿勒丁医疗公司 新型纳米颗粒组合物
WO2015200054A2 (fr) 2014-06-24 2015-12-30 The Trustees Of Princeton University Procédé d'encapsulation de composés biologiques, thérapeutiques et agents d'imagerie solubles
EP3393647A4 (fr) * 2015-12-22 2019-08-21 The Trustees of Princeton University Procédé d'encapsulation de composés biologiques, thérapeutiques et d'agents d'imagerie solubles
CN110198703A (zh) 2016-11-21 2019-09-03 艾里奥治疗公司 大试剂的透皮递送
WO2019055539A1 (fr) 2017-09-12 2019-03-21 Prudhomme Robert K Nanoparticules de polymère cellulosique et leurs procédés de formation
US11731099B2 (en) 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014415A1 (fr) * 1992-12-24 1994-07-07 Hemagen/Pfc Emulsions d'hydrocarbure fluore
WO1997021425A1 (fr) * 1995-12-14 1997-06-19 Alliance Pharmaceutical Corp. Preparations huile hydrocarbure/composes fluores et methodes d'utilisation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014415A1 (fr) * 1992-12-24 1994-07-07 Hemagen/Pfc Emulsions d'hydrocarbure fluore
WO1997021425A1 (fr) * 1995-12-14 1997-06-19 Alliance Pharmaceutical Corp. Preparations huile hydrocarbure/composes fluores et methodes d'utilisation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GUSTAFSSON ET AL: "Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer", LANGMUIR, AMERICAN CHEMICAL SOCIETY, NEW YORK, NY, US, vol. 13, 1997, pages 6964 - 6971, XP002344326, ISSN: 0743-7463 *
See also references of WO02076441A1 *

Also Published As

Publication number Publication date
WO2002076441A1 (fr) 2002-10-03
CA2445125A1 (fr) 2002-10-03
EP1379227A1 (fr) 2004-01-14

Similar Documents

Publication Publication Date Title
EP1379227A4 (fr) Micro-emulsions en tant que precurseurs de nanoparticules solides
GB0106247D0 (en) Improvements relating to supports
IL172206A0 (en) Solid preparation
GB0109143D0 (en) Antiperspirant compositions comprising microemulsions
AU2003277279A8 (en) Nanometric composites as improved dielectric structures
AU2002359659A8 (en) Cross reference to related application
GB0120366D0 (en) Nanostructure synthesis
GB0116074D0 (en) Nanoparticle structures
HUP0303021A3 (en) Microemulsions
GB2391000B (en) Formable composites
IL162158A0 (en) Prodrugs to d-prolines
GB2382086B (en) Improvements relating to foundation rafts
AU2002250414A1 (en) Microemulsions as precursors to solid nanoparticles
GB0116230D0 (en) Improvements to wrenches
GB2393515B (en) Improvements to surface pointing techniques
GB2393932B (en) Surface preparation
TW461552U (en) Improvement of seven-string ancient lute
GB0122196D0 (en) Improvements to the n-plex transceiver
GB0125819D0 (en) Improvements to flooring
TW494960U (en) Anti-thieving structure able to lock quickly
GB0108921D0 (en) Improvements to seating
GB0117022D0 (en) Improvements relating to gears
GB0116967D0 (en) Improvements relating to chitosan
GB0108898D0 (en) Functioniseable nanoparticles
GB0111393D0 (en) Improvements relating to implants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031021

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20071108

17Q First examination report despatched

Effective date: 20100120

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100601